Market Tracker

05/27 5:16pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.55
Delayed Data
As of May 27
 +0.02 / +1.31%
Today’s Change
1.43
Today|||52-Week Range
5.15
-35.95%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.53
Today’s open1.54
Day’s range1.53 - 1.58
Volume147,942
Average volume (3 months)213,028
Market cap$70.3M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+24.18%
Earnings growth (this year)+31.12%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+166.39%
P/E ratioNM
Price/Sales4.79
Price/Book--

Competitors

 Today’s
change
Today’s
% change
APDNApplied DNA Sciences...+0.05+1.77%
NVLSNivalis Therapeutics...+0.11+2.36%
ZYNEZynerba Pharmaceutic...+0.16+2.11%
VCELVericel Corp-0.02-0.71%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$22.4M
Annual profit (last year)-$30.6M
Net profit margin-136.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts